Hepatitis C virus escape studies for human monoclonal antibody AR4A reveal isolate-specific resistance and a high barrier to resistance

    Rodrigo Velázquez-Moctezuma
    Rodrigo Velázquez-Moctezuma

    The Journal of infectious diseases, 2018.

    Cited by: 2|Bibtex|Views0|Links
    WOS

    Abstract:

    Global control of hepatitis C virus (HCV) depends on development of a prophylactic vaccine. We studied escape for cross-genotype-reactive neutralizing antibody AR4A, providing valuable information for HCV vaccine design. We cultured HCV Core-NS2 recombinants H77(genotype 1a)/JFH1 or the highly-antibody-sensitive hypervariable region 1 (HV...More

    Code:

    Data:

    Your rating :
    0

     

    Tags
    Comments